» Articles » PMID: 38443816

Vitamin a Potentiates Sheep Myoblasts Myogenic Differentiation Through BHLHE40-modulated ID3 Expression

Overview
Journal BMC Genomics
Publisher Biomed Central
Specialty Genetics
Date 2024 Mar 5
PMID 38443816
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Vitamin A and retinoic acid (RA, a metabolite of vitamin A), are inextricably involved to the development of skeletal muscle in animals. However, the mechanisms regulating skeletal muscle development by vitamin A remain poorly reported. The current study designed to investigate the underlying mechanism of vitamin A affecting myogenic differentiation of lamb myoblasts through transcriptome sequencing (RNA-Seq) and gene function validation experiments. It provides a theoretical basis for elucidating the regulation of vitamin A on skeletal muscle development as well as for improving the economic benefits of the mutton sheep industry.

Results: Newborn lambs were injected with 7,500 IU vitamin A, and longissimus dorsi (LD) muscle tissue was surgically sampled for RNA-Seq analysis and primary myoblasts isolation at 3 weeks of age. The results showed that a total of 14 down-regulated and 3 up-regulated genes, were identified between control and vitamin A groups. Among them, BHLHE40 expression was upregulated in vitamin A group lambs. Furthermore, BHLHE40 expression is significantly increased after initiation of differentiation in myoblasts, and RA addition during differentiation greatly promoted BHLHE40 mRNA expression. In vitro, RA inhibited myoblasts proliferation and promoted myoblasts myogenic differentiation through BHLHE40. Moreover, BHLHE40 was proved to inhibit the expression of the DNA binding inhibitor 3 (ID3), and meanwhile, ID3 could effectively promote myoblasts proliferation and inhibit myoblasts myogenic differentiation.

Conclusions: Taken together, our results suggested that vitamin A inhibited myoblasts proliferation and promoted myoblasts myogenic differentiation by inhibiting ID3 expression through BHLHE40.

Citing Articles

Review of Liquid Vitamin A and E Formulations in Veterinary and Livestock Production: Applications and Perspectives.

Shastak Y, Pelletier W Vet Sci. 2024; 11(9).

PMID: 39330800 PMC: 11435926. DOI: 10.3390/vetsci11090421.


Bhlhe40 Regulates Proliferation and Angiogenesis in Mouse Embryoid Bodies under Hypoxia.

Acosta-Iborra B, Gil-Acero A, Sanz-Gomez M, Berrouayel Y, Puente-Santamaria L, Alieva M Int J Mol Sci. 2024; 25(14).

PMID: 39062912 PMC: 11277088. DOI: 10.3390/ijms25147669.

References
1.
Weidemuller P, Kholmatov M, Petsalaki E, Zaugg J . Transcription factors: Bridge between cell signaling and gene regulation. Proteomics. 2021; 21(23-24):e2000034. DOI: 10.1002/pmic.202000034. View

2.
Chaudhary J, Johnson J, Kim G, Skinner M . Hormonal regulation and differential actions of the helix-loop-helix transcriptional inhibitors of differentiation (Id1, Id2, Id3, and Id4) in Sertoli cells. Endocrinology. 2001; 142(5):1727-36. DOI: 10.1210/endo.142.5.8134. View

3.
Roschger C, Cabrele C . The Id-protein family in developmental and cancer-associated pathways. Cell Commun Signal. 2017; 15(1):7. PMC: 5267474. DOI: 10.1186/s12964-016-0161-y. View

4.
Love M, Huber W, Anders S . Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014; 15(12):550. PMC: 4302049. DOI: 10.1186/s13059-014-0550-8. View

5.
Donato L, Suh J, Noy N . Suppression of mammary carcinoma cell growth by retinoic acid: the cell cycle control gene Btg2 is a direct target for retinoic acid receptor signaling. Cancer Res. 2007; 67(2):609-15. DOI: 10.1158/0008-5472.CAN-06-0989. View